Chronic suppurative otitis media.
Chronic suppurative suppurative
pertaining to or emanating from suppuration; pus in e.g. suppurative arthritis, bronchopneumonia. otitis media (CSOM) is a stage of ear disease in which there is chronic infection of the middle-ear cleft, i.e. the eustachian tube, middle ear and mastoid, and in which a non-intact tympanic membrane (e.g. perforation or tympanostomy tube) and discharge (otorrhoea) are present. (1) The perforation can result as a complication or as sequelae of acute otitis media, trauma or extrusion or removal of a tympanostomy tube. (1) Prevalence surveys, which vary widely in disease definition, sampling methods and methodological quality, show that the global burden of illness from CSOM involves 65 - 330 million individuals with draining ears, 60% of whom (39 - 200 million) suffer from significant hearing impairment. (2)
Patients with CSOM may consult a doctor with one of the following: (2)
* a newly discharging untreated ear
* a persistently discharging initially treated ear
* a recurrently discharging ear
* a discharging ear with headache, fever, dizziness and other danger signs, or
* a dry, perforated eardrum with hearing loss.
[FIGURE 1 OMITTED]
The first two conditions can be treated at primary care level, with dry ear mopping and appropriate topical antimicrobials. A swab can be taken to confirm the organisms involved. Referral for specialist treatment is indicated in cases of suspected complications, cases not responsive to treatment or cases of hearing loss (Fig. 1).
The organisms involved differ from those implicated in acute otitis media and include aerobic organisms, predominantly Staphylococcus aureus and Pseudomonas aeruginosa (Proteus spp. in a local study) as well as anaerobic anaerobic /an·aer·o·bic/ (an?ah-ro´bik)
1. lacking molecular oxygen.
2. growing, living, or occurring in the absence of molecular oxygen; pertaining to an anaerobe. organisms of which Peptostreptococcus spp. occur most commonly. (3)
The aims of treatment are to clear up the otorrhoea, close the tympanic membrane perforation, improve the hearing loss and prevent complications. In a Cochrane review undertaken in 2005, it was found that topical antibiotics are more effective in treating discharging ears with an underlying perforation than either systemic antibiotics or topical antiseptics. (4) The introduction of quinolone eardrops ear·drops
Liquid medicine administered into the ear.
n.pl oil-, water-, or alchol-based treatment that is placed in the ear. Used to treat inflammation and infections of the ear canal. in 1998 heralded a new era in ototopic treatment, largely replacing gentamycin-containing drops with their well-known ototoxic ototoxic /oto·tox·ic/ (o´to-tok?sik) having a deleterious effect upon the eighth nerve or on the organs of hearing and balance.
adj. potential. (5) Surgery is often needed.
Cholesteatoma is a destructive lesion consisting of keratinising stratified squamous epithelium in the middle ear and/or mastoid. It should be suspected in cases of offensive otorrhoea, cases not responding to appropriate treatment and in those with complications. The definitive treatment for cholesteatoma is surgical, the extent of disease dictating the type of procedure indicated.
Although complications have decreased since the introduction of antibiotics early in the 20th century, they continue to occur, and can be lethal if they are not identified and treated properly.
external to the cranial vault.
when the cause of the convulsions is external to the brain, e.g. hypocalcemic tetanic convulsions. complications
Subperiosteal subperiosteal /sub·peri·os·te·al/ (-per-e-os´te-al) beneath the periosteum.
subperiosteal, (sub´perēos´tē abscess, also referred to as acute mastoiditis mastoiditis
Inflammation of the mastoid process, a bony projection just behind the ear, almost always due to otitis media. It may spread into small cavities in the bone, blocking their drainage. Very severe cases infect the whole middle ear cleft. , is the most common complication of CSOM and can occur with or without the presence of a cholesteatoma. The abscess occurs over the mastoid cortex when the infectious process within the mastoid air cells extends into the subperiosteal space. The diagnosis of a subperiosteal abscess is often made clinically. Commonly, the patient will present with systemic symptoms, including fever and malaise, along with local signs, such as a protruding auricle auricle /au·ri·cle/ (aw´ri-k'l)
1. pinna; the flap of the ear.
2. the ear-shaped appendage of either atrium of the heart.
3. formerly, the atrium of the heart. that is laterally and inferiorly displaced, and the presence of a fluctuant, erythematous, tender area behind the ear. A CT scan might be indicated to evaluate the extent of the disease and help in therapeutic planning, exclude intracranial complications or confirm the diagnosis in uncertain cases. (6) Treatment includes incision and drainage of the abscess in conjunction with intravenous antibiotics as well as ear toilet and topical treatment. Whether or not a cortical mastoidectomy should be performed in all cases is controversial. Surgery would certainly be indicated in patients with underlying cholesteatoma, but this may be delayed (Fig. 2).
Other extracranial complications include Bezold's abscess, labyrinthine fistulae, facial nerve paralysis and petrous petrous /pet·rous/ (pet´rus) resembling a rock; hard; stony.
1. Of stony hardness.
2. apicitis (Gradenigo's syndrome). (6')
[FIGURE 2 OMITTED]
Meningitis is the most common intracranial complication of acute and chronic otitis media. Signs that should increase the suspicion of an intracranial complication include persistent or intermittent fever, nausea and vomiting, irritability, lethargy, or persistent headache. Ominous signs virtually diagnostic of an intracranial process include visual changes, new-onset seizures, nuchal rigidity, ataxia, or decreased mental status. If any of these suspicious or ominous signs occur, immediate treatment and further work-up are critical. Broad-spectrum antibiotics, such as third-generation cephalosporins, should be administered while diagnostic tests are ordered and arranged. A contrasted CT scan or an MRI will show characteristic meningeal me·nin·ge·al
Of, relating to, or affecting the meninges.
pertaining to the meninges.
meningeal hemorrhage enhancement and rule out additional intracranial complications known to occur in up to 50% of these cases. In the absence of a significant mass effect on imaging, a lumbar puncture should be performed to confirm the diagnosis and to allow for culture and sensitivity testing. (6)
Other intracranial complications are brain and epidural abscesses, lateral sinus thrombosis and otitic hydrocephalus. (6)
Theresa Erasmus, MMed ORL
Senior Specialist, Department of Otorhinolaryngology, University of the Free State, Bloemfontein
Correspondence to: T Erasmus (email@example.com)
References available at www.cmej.org.za